Giving the immunotherapy nivolumab to patients with oral proliferative leukoplakia not only reduces lesions but also may prevent cancer progression, suggests the first study in the preventive setting.
Medscape Medical News
Could Nivolumab Prevent Oral Cancer in High-Risk Patients?
